NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT00630409 2017-03-10Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell CarcinomaUniversity of PittsburghPhase 2 Completed5 enrolled 2 charts